These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 25560701)

  • 1. Therapeutic aptamers: developmental potential as anticancer drugs.
    Lee JW; Kim HJ; Heo K
    BMB Rep; 2015 Apr; 48(4):234-7. PubMed ID: 25560701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Methods for Purification and Structure Determination of Oligonucleotides.
    Zhang Q; Lv H; Wang L; Chen M; Li F; Liang C; Yu Y; Jiang F; Lu A; Zhang G
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers.
    Zhou G; Latchoumanin O; Hebbard L; Duan W; Liddle C; George J; Qiao L
    Adv Drug Deliv Rev; 2018 Sep; 134():107-121. PubMed ID: 29627370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenging cancer targets for aptamer delivery.
    de Franciscis V
    Biochimie; 2018 Feb; 145():45-52. PubMed ID: 28962871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents.
    Kim M; Kim DM; Kim KS; Jung W; Kim DE
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivalent Aptamers: Versatile Tools for Diagnostic and Therapeutic Applications.
    Vorobyeva M; Vorobjev P; Venyaminova A
    Molecules; 2016 Nov; 21(12):. PubMed ID: 27898020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application.
    Adachi T; Nakamura Y
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31766318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamers as targeting delivery devices or anti-cancer drugs for fighting tumors.
    Scaggiante B; Dapas B; Farra R; Grassi M; Pozzato G; Giansante C; Fiotti N; Tamai E; Tonon F; Grassi G
    Curr Drug Metab; 2013 Jun; 14(5):565-82. PubMed ID: 23687927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic acid aptamers based on the G-quadruplex structure: therapeutic and diagnostic potential.
    Gatto B; Palumbo M; Sissi C
    Curr Med Chem; 2009; 16(10):1248-65. PubMed ID: 19355883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamer applications for targeted cancer therapy.
    Barbas AS; Mi J; Clary BM; White RR
    Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.
    Zhu H; Li J; Zhang XB; Ye M; Tan W
    ChemMedChem; 2015 Jan; 10(1):39-45. PubMed ID: 25277749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology and aptamers: applications in drug delivery.
    Levy-Nissenbaum E; Radovic-Moreno AF; Wang AZ; Langer R; Farokhzad OC
    Trends Biotechnol; 2008 Aug; 26(8):442-9. PubMed ID: 18571753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
    Li X; Zhao Q; Qiu L
    J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection and Application of Aptamers and Intramers.
    Avci-Adali M
    Adv Exp Med Biol; 2016; 917():241-58. PubMed ID: 27236559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting cancer cells with nucleic acid aptamers.
    Cerchia L; de Franciscis V
    Trends Biotechnol; 2010 Oct; 28(10):517-25. PubMed ID: 20719399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Selection, Modification and Development of Therapeutic Oligonucleotide Aptamers.
    Yu Y; Liang C; Lv Q; Li D; Xu X; Liu B; Lu A; Zhang G
    Int J Mol Sci; 2016 Mar; 17(3):358. PubMed ID: 26978355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of Specific Aptamers.
    Liu S; Suzuki Y; Inui M
    Methods Mol Biol; 2018; 1868():113-121. PubMed ID: 30244458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ssDNA aptamers that selectively bind oxytetracycline.
    Niazi JH; Lee SJ; Kim YS; Gu MB
    Bioorg Med Chem; 2008 Feb; 16(3):1254-61. PubMed ID: 17988875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro selection of RNA aptamers to a small molecule target.
    Codrea V; Hayner M; Hall B; Jhaveri S; Ellington A
    Curr Protoc Nucleic Acid Chem; 2010 Mar; Chapter 9():Unit 9.5.1-23. PubMed ID: 20201029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.